Search
for
Sort by
Research 361–390 of 1000+
- A Recurrent Intragenic Deletion in the Desmoglein 4 Gene Underlies Localized Autosomal Recessive Hypotrichosis
- <i>De novo</i> mutations in monilethrix
- Compound Heterozygous Mutations in the Hairless Gene in Atrichia with Papular Lesions
- Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India
- Atrichia with papular lesions resulting from a novel homozygous missense mutation in the hairless gene
- Successful White Hair Removal with Combined Coloring and Intense Pulsed Light (IPL): A Randomized Clinical Trial
- Desmoglein 4 Mutations Underlie Localized Autosomal Recessive Hypotrichosis in Humans, Mice, and Rats
- Frontal fibrosing alopecia in men: A multicenter study of 39 patients
- Varying Presentation of Type 1 Polyglandular Failure in India
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Prenatal Screening for Bathing-suit Ichthyosis After Diagnosis in an Older Sibling
- Sparse Brittle Hair and Bilateral Temporal Alopecia in a Child
- Baricitinib-Induced Trichilemmal Cyst Reactivation in a Woman With Alopecia Areata
- Patchy acute effluvium in and around the donor area following FUE hair transplant and its predilection for two-day session and high graft extraction cases
- 51252 Oral supplementation with L-Cystine, Serenoa repens, Pumpkin seed oil and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A double-blind, placebo-controlled, randomized clinical study
- Oral Supplementation with l-Cystine, <i>Serenoa repens</i>, <i>Cucurbita pepo</i>, and <i>Pygeum africanum</i> in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study
- Nanocarriers for melatonin delivery
- Faculty Opinions recommendation of Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia.
- Faculty Opinions recommendation of Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
- Faculty Opinions recommendation of Enhanced effect of platelet-rich plasma containing a new carrier on hair growth.
- Faculty Opinions recommendation of Promising therapies for treating and/or preventing androgenic alopecia.
- Faculty Opinions recommendation of There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses.
- Faculty Opinions recommendation of Mesotherapy with dutasteride for androgenetic alopecia: A retrospective study in real clinical practice.
- Faculty Opinions recommendation of Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.
- Faculty Opinions recommendation of Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
- Faculty Opinions recommendation of Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”.
- Faculty Opinions recommendation of Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
- Faculty Opinions recommendation of Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia.
- Faculty Opinions recommendation of Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
- Faculty Opinions recommendation of Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial.